Advion Acquires NanoTek; Plans to Offer Combined Microfluidics Platform for Biomarker Research | GenomeWeb
NEW YORK (GenomeWeb News) - Bioanalytical contract services provider Advion BioSciences this week said it has acquired microfluidic chemistry firm NanoTek for an undisclosed sum.
Advion said it plans to use NanoTek's technology in combination with its own micro- and nanoscale LC-MS analytical platform to offer chemistry and analytical services for biomarker research, drug discovery, and imaging diagnostics.
Prior to the acquisition, Advion was NanoTek’s global distribution and support partner.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.